Insider plans sale of 13,750 ordinary shares

Yoav Gazelle has filed a notice to sell 13,750 ordinary shares of RDWR under Rule 144.

Rhea-AI Filing Summary

Yoav Gazelle has filed a notice to sell 13,750 ordinary shares of RDWR under Rule 144. The planned sale, through Oppenheimer & Co. Inc. on Nasdaq, has an aggregate market value of 362,862.50, based on the figures in the notice.

The shares come from exercises of employee stock options originally acquired on 02/08/2022 and 10/31/2023, with cash payment upon exercise on 02/13/2026. The notice also reports that Gazelle sold 2,750 ordinary shares on 02/11/2026 for gross proceeds of 78,347.50, and that 42,554,602 shares were outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the RDWR Form 144 filing by Yoav Gazelle disclose?

The filing discloses that Yoav Gazelle intends to sell 13,750 RDWR ordinary shares under Rule 144. The sale will be executed through Oppenheimer & Co. Inc. on Nasdaq, based on shares obtained via the company’s employee stock option plan and exercised for cash.

How many RDWR shares is Yoav Gazelle planning to sell under Rule 144?

Yoav Gazelle plans to sell 13,750 ordinary shares of RDWR. The filing shows an aggregate market value of 362,862.50 for these shares, with Oppenheimer & Co. Inc. listed as broker and Nasdaq as the exchange where the sale is expected to occur.

How were the RDWR shares in Yoav Gazelle’s Form 144 acquired?

The RDWR shares were acquired through the company’s employee stock option plan. The notice lists acquisition dates of 02/08/2022 and 10/31/2023, with options to be exercised for cash on 02/13/2026 before the planned Rule 144 sale of 13,750 ordinary shares.

Has Yoav Gazelle sold RDWR shares in the last three months?

Yes. The notice reports that Yoav Gazelle sold 2,750 RDWR ordinary shares on 02/11/2026. Those shares generated gross proceeds of 78,347.50, and this prior sale is disclosed as required for aggregation under Rule 144’s volume and reporting provisions.

What is the outstanding share count referenced in the RDWR Form 144?

The Form 144 states that 42,554,602 RDWR ordinary shares were outstanding. This figure serves as a baseline to assess the size of Yoav Gazelle’s proposed 13,750-share sale under Rule 144 relative to the company’s total ordinary shares in the market.

Which broker and exchange are involved in Yoav Gazelle’s planned RDWR sale?

The planned Rule 144 sale will use Oppenheimer & Co. Inc. as broker. The filing lists Oppenheimer’s New York address and names Nasdaq as the securities exchange where the 13,750 RDWR ordinary shares are expected to be sold, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:27 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002053248
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RADWARE LTD
SEC File Number	000-30324
Address of Issuer	22 RAOUL WALLENBERG STREET TEL AVIV ISRAEL 69710
Phone	201 512 9771
Name of Person for Whose Account the Securities are To Be Sold	Gazelle Yoav
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	13750	362862.50	42554602	02/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	02/08/2022	Employee Stock Option Plan	From the Issuer			8750	02/13/2026	Cash Upon Exercise
Ordinary Shares	10/31/2023	Employee Stock Option Plan	From the Issuer			5000	02/13/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Yoav Gazelle 22 Raoul Wallenberg st Tel Aviv L3 69710	Ordinary	02/11/2026	2750	78347.50

144: Remarks and Signature

Remarks
Date of Notice	02/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Yoav Gazelle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)